Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Rhamnose
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Rhamnose

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A methylpentose, or 6-deoxy-hexose, whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (773 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A methylpentose, or 6-deoxy-hexose, whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Deoxymannose; Rhamnose, L-Isomer; Rhamnose, L Isomer.

Where it fits in the MeSH classification

Broader topics
Deoxy Sugars; Mannose; Pentoses

Research landscape

PubMed indexes 2,121 records tagged with the MeSH heading “Rhamnose” (counts retrieved 2026-10-31). 272 of them (12.8%) were published from 2020 onward, and the busiest period so far is through 1999 with 1,035 records.

Reviews account for 47 records (2.2%) and meta-analyses for 0. Randomized controlled trials number 33 (1.6%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,035 records; 2000-2009: 392 records; 2010-2019: 422 records; 2020 onward: 272 records1,035through 19993922000-20094222010-20192722020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,035
2000-2009392
2010-2019422
2020 onward272
Share of records by publication typeReviews: 2.2 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 1.6 percentReviews2.2% (47)Meta-analyses0.0% (0)Randomized controlled trials1.6% (33)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,121 PubMed records
TypeRecordsShare
Reviews472.2%
Meta-analyses00.0%
Randomized controlled trials331.6%

Method: PubMed query "Rhamnose"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria
Mistou MY, Sutcliffe IC, van Sorge NM
2016Review article
Design not recorded in structured metadata
175cc by
PMID 26975195 · DOI · PMC4931226
Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations
Wegerer A, Sun T, Altenbuchner J
2008Research article
Design not recorded in structured metadata
85cc by
PMID 18194555 · DOI · PMC2254391
L-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the Membrane
Carvalho F, Atilano ML, Pombinho R, Covas G, Gallo RL, Filipe SR, et al.
2015Research article
Design not recorded in structured metadata
77cc by
PMID 26001194 · DOI · PMC4441387
Novel utilization of the seaweed-based deoxy sugars rhamnose and fucose by engineered Corynebacterium glutamicum
Stephansen IM, Brito LF, Auran OS, Lande SS, Pérez-García F
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42277824 · DOI · PMC13479540

Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria [1]

Review article Mistou MY, Sutcliffe IC, van Sorge NM · · 2016 · cited 175 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The composition of the Gram-positive cell wall is typically described as containing peptidoglycan, proteins and essential secondary cell wall structures called teichoic acids, which comprise approximately half of the cell wall mass.
Closing excerpt
We also briefly discuss how increased knowledge in this field can provide interesting leads for new therapeutic compounds and improve biotechnological applications.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (176 words)

The composition of the Gram-positive cell wall is typically described as containing peptidoglycan, proteins and essential secondary cell wall structures called teichoic acids, which comprise approximately half of the cell wall mass. The cell walls of many species within the genera Streptococcus, Enterococcus and Lactococcus contain large amounts of the sugar rhamnose, which is incorporated in cell wall-anchored polysaccharides (CWP) that possibly function as homologues of well-studied wall teichoic acids (WTA). The presence and chemical structure of many rhamnose-containing cell wall polysaccharides (RhaCWP) has sometimes been known for decades. In contrast to WTA, insight into the biosynthesis and functional role of RhaCWP has been lacking. Recent studies in human streptococcal and enterococcal pathogens have highlighted critical roles for these complex polysaccharides in bacterial cell wall architecture and pathogenesis. In this review, we provide an overview of the RhaCWP with regards to their biosynthesis, genetics and biological function in species most relevant to human health. We also briefly discuss how increased knowledge in this field can provide interesting leads for new therapeutic compounds and improve biotechnological applications.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26975195 · DOI · PMC4931226

Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations [2]

Research article Wegerer A, Sun T, Altenbuchner J · · 2008 · cited 85 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundA capable expression vector is mainly characterized by its production efficiency, stability and induction response.
Closing excerpt
The genetic modules showed a complex interplay, therefore two positive effects combined sometimes resulted in a disadvantage.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (153 words)

BackgroundA capable expression vector is mainly characterized by its production efficiency, stability and induction response. These features can be influenced by a variation of modifications and versatile genetic modules.ResultsWe examined miscellaneous variations of a rhaPBAD expression vector. The introduction of a stem loop into the translation initiation region of the rhaPBAD promoter resulted in the most significant improvement of eGFP expression. Starting from this plasmid, we constructed a set of expression vectors bearing different genetic modules like rop, ccdAB, cer and combinations thereof, and tested the efficiency of expression and plasmid stability. The plasmid pWA21, containing the stem loop, one cer site and rop, attained high expression levels accompanied by a good stability, and on that score seems to be a well-balanced choice.ConclusionWe report the generation of variations of the rhaPBAD expression vector and characterization hereof. The genetic modules showed a complex interplay, therefore two positive effects combined sometimes resulted in a disadvantage.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 18194555 · DOI · PMC2254391

L-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the Membrane [3]

Research article Carvalho F, Atilano ML, Pombinho R, Covas G, Gallo RL, Filipe SR, et al. · · 2015 · cited 77 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen responsible for listeriosis, a human foodborne disease.
Closing excerpt
monocytogenes virulence in a mouse model of infection.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (230 words)

Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen responsible for listeriosis, a human foodborne disease. Its cell wall is densely decorated with wall teichoic acids (WTAs), a class of anionic glycopolymers that play key roles in bacterial physiology, including protection against the activity of antimicrobial peptides (AMPs). In other Gram-positive pathogens, WTA modification by amine-containing groups such as D-alanine was largely correlated with resistance to AMPs. However, in L. monocytogenes, where WTA modification is achieved solely via glycosylation, WTA-associated mechanisms of AMP resistance were unknown. Here, we show that the L-rhamnosylation of L. monocytogenes WTAs relies not only on the rmlACBD locus, which encodes the biosynthetic pathway for L-rhamnose, but also on rmlT encoding a putative rhamnosyltransferase. We demonstrate that this WTA tailoring mechanism promotes resistance to AMPs, unveiling a novel link between WTA glycosylation and bacterial resistance to host defense peptides. Using in vitro binding assays, fluorescence-based techniques and electron microscopy, we show that the presence of L-rhamnosylated WTAs at the surface of L. monocytogenes delays the crossing of the cell wall by AMPs and postpones their contact with the listerial membrane. We propose that WTA L-rhamnosylation promotes L. monocytogenes survival by decreasing the cell wall permeability to AMPs, thus hindering their access and detrimental interaction with the plasma membrane. Strikingly, we reveal a key contribution of WTA L-rhamnosylation for L. monocytogenes virulence in a mouse model of infection.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26001194 · DOI · PMC4441387

Novel utilization of the seaweed-based deoxy sugars rhamnose and fucose by engineered Corynebacterium glutamicum [4]

Research article Stephansen IM, Brito LF, Auran OS, Lande SS, Pérez-García F · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Seaweed represents a potential sustainable carbon source for industrial biotechnology, yet the workhorse bacterium Corynebacterium glutamicum cannot naturally metabolize the deoxy sugars L-rhamnose and L-fucose, abundant in green and brown seaweed, respectively.
Closing excerpt
Growth and L-lysine production on seaweed hydrolysates highlights the potential of this approach for sustainable marine biomass valorization and bioproduction of value-added compounds.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (214 words)

Seaweed represents a potential sustainable carbon source for industrial biotechnology, yet the workhorse bacterium Corynebacterium glutamicum cannot naturally metabolize the deoxy sugars L-rhamnose and L-fucose, abundant in green and brown seaweed, respectively. Expanding its substrate range is crucial for sustainable bioprocessing, by enabling utilization of the available biomass. In this study, we engineered C. glutamicum to utilize L-rhamnose and L-fucose by introducing the Escherichia coli operons rhaBADM and fucIKUA, enabling growth on these sugars as sole carbon sources. To enhance growth, we evaluated various transport systems and identified the non-native fucose permease (FucP) as the most efficient for L-rhamnose uptake, and the native myo-inositol transporter 2 (IolT2) as optimal for L-fucose uptake. During L-rhamnose and L-fucose utilization, L-lactaldehyde is formed as a byproduct. We demonstrate that the native acetaldehyde dehydrogenase encoded by ald also exhibits lactaldehyde dehydrogenase activity, and that its overexpression enhances L-lactaldehyde utilization. Finally, cultivation on green and brown seaweed hydrolysates enabled the engineered strains to achieve increased biomass formation through consumption of the targeted deoxy sugars. This study expands the substrate spectrum of C. glutamicum through pathway engineering, transport optimization, and functional identification of a native lactaldehyde dehydrogenase. Growth and L-lysine production on seaweed hydrolysates highlights the potential of this approach for sustainable marine biomass valorization and bioproduction of value-added compounds.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42277824 · DOI · PMC13479540

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Rhamnose lipids--biosynthesis, microbial production and application potential [5]
    Lang S, Wullbrandt D · Appl Microbiol Biotechnol · 1999 · cited 229 times (Europe PMC)
  • Research article The rhamnose pathway [6]
    Giraud MF, Naismith JH · Curr Opin Struct Biol · 2000 · cited 181 times (Europe PMC)
  • Research article Advances in applications of rhamnolipids biosurfactant in environmental remediation: A review [7]
    Liu G, Zhong H, Yang X, Liu Y, Shao B, Liu Z · Biotechnol Bioeng · 2018 · cited 89 times (Europe PMC)
  • Research article Rhamnose in plants - from biosynthesis to diverse functions [8]
    Jiang N, Dillon FM, Silva A, Gomez-Cano L, Grotewold E · Plant Sci · 2021 · cited 77 times (Europe PMC)
  • Research article The metabolism of 6-deoxyhexoses in bacterial and animal cells [9]
    Tonetti M, Sturla L, Bisso A, Zanardi D, Benatti U, De Flora A · Biochimie · 1998 · cited 45 times (Europe PMC)
  • Research article Rhamnose-Containing Compounds: Biosynthesis and Applications [10]
    Li S, Chen F, Li Y, Wang L, Li H, Gu G, et al. · Molecules · 2022 · cited 36 times (Europe PMC)

References

  1. Mistou MY, Sutcliffe IC, van Sorge NM. Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria. . 2016. PMID 26975195 · DOI · PMC4931226
  2. Wegerer A, Sun T, Altenbuchner J. Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations. . 2008. PMID 18194555 · DOI · PMC2254391
  3. Carvalho F, Atilano ML, Pombinho R, Covas G, Gallo RL, Filipe SR, et al.. L-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the Membrane. . 2015. PMID 26001194 · DOI · PMC4441387
  4. Stephansen IM, Brito LF, Auran OS, Lande SS, Pérez-García F. Novel utilization of the seaweed-based deoxy sugars rhamnose and fucose by engineered Corynebacterium glutamicum. . 2026. PMID 42277824 · DOI · PMC13479540
  5. Lang S, Wullbrandt D. Rhamnose lipids--biosynthesis, microbial production and application potential. Appl Microbiol Biotechnol. 1999. PMID 10077819 · DOI
  6. Giraud MF, Naismith JH. The rhamnose pathway. Curr Opin Struct Biol. 2000. PMID 11114506 · DOI
  7. Liu G, Zhong H, Yang X, Liu Y, Shao B, Liu Z. Advances in applications of rhamnolipids biosurfactant in environmental remediation: A review. Biotechnol Bioeng. 2018. PMID 29240227 · DOI
  8. Jiang N, Dillon FM, Silva A, Gomez-Cano L, Grotewold E. Rhamnose in plants - from biosynthesis to diverse functions. Plant Sci. 2021. PMID 33288005 · DOI
  9. Tonetti M, Sturla L, Bisso A, Zanardi D, Benatti U, De Flora A. The metabolism of 6-deoxyhexoses in bacterial and animal cells. Biochimie. 1998. PMID 9893952 · DOI
  10. Li S, Chen F, Li Y, Wang L, Li H, Gu G, et al.. Rhamnose-Containing Compounds: Biosynthesis and Applications. Molecules. 2022. PMID 36014553 · DOI · PMC9415975

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • GlyceraldehydeDrugs and Chemicals
  • ColchicineDrugs and Chemicals
  • CamphorDrugs and Chemicals
  • AldosteroneDrugs and Chemicals
  • CyproteroneDrugs and Chemicals
  • MonocrotalineDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

2,121
PubMed records on this heading
13%
published since 2020
47
review articles
33
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • GlyceraldehydeDrugs and Chemicals
  • ColchicineDrugs and Chemicals
  • CamphorDrugs and Chemicals
  • AldosteroneDrugs and Chemicals
  • CyproteroneDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support